accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
Published 1 year ago • 219 plays • Length 4:22Download video MP4
Download video MP3
Similar videos
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
1:16
insights into the phase ii smart stop study
-
1:30
insights into the manifest-2 study
-
2:01
the evolution of bcl2 inhibition in cll
-
1:44
insights into the phase ii tidal study
-
1:01:32
exclusive : merging modern concepts of immunology & precision medicine to immunotherapeutics by mirm
-
55:44
a2 psychology (9990) syllabus and paper structure explained.
-
2:57
innovation japan : ai to advance regenerative medicine
-
2:26
emerging immunotherapeutic strategies for multiple myeloma in the frontline and r/r settings
-
3:18
a phase i study of jbh492, an anti-ccr7 antibody-drug conjugate, in lymphoid malignancies
-
1:00
proof of principle to progress treatments
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
1:35
phase i/ii bruin update: efficacy of pirtobrutinib in r/r waldenström's macroglobulinemia
-
1:25
insights into a phase ii study evaluating anx005 in waiha
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
1:45
a phase ii study of elritercept for lower-risk mds
-
4:48
an insight into the management of cytopenias in mf
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
1:40
utilizing ai for individualized treatment-adjusted risk stratification in newly diagnosed myeloma
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
0:50
the expanding therapeutic landscape of r/r multiple myeloma